Journal of Business & Technology Law

"The Future of Genetic Disease Diagnosis and Treatment: Do Patents Matter?"

On Friday, April 2, 2010, the Journal, along with the Intellectual Property Law Program, co-sponsored a symposium focusing on the eligibility of genes, research methods, and diagnostic kits as patentable subject matter. The symposium featured panel discussions and incorporated dialogue concerning Bilski and the ongoing case, Ass'n for Molecular Pathology v. U.S. Patent & Trademark Office. The keynote speaker was Ms. Arti Rai, former Duke Law Professor and current Administrator for External Affairs at the

The Journal would like to thank the panelists and attendees for their lively and informative discussion.

A video of the symposium is posted below in two parts.

 

Past Symposia

Spring 2013: Social Media & The Law

Fall 2012: Business Arbitration: Redefining the Landscape of Efficient Business Practices

Spring 2012: Cybersecurity: Safeguarding Information in a Digital Age

Fall 2011: The Intersection of Sports and Business in Today's Legal Arena

Spring 2011: Confronting the Challenges of Counterfeiting in Practice and Policy.

Fall 2010: The Economic Impact of the Dodd-Frank Bill.

Spring 2010: The Future of Genetic Disease Diagnosis and Treatment: Do Patents Matter?


Back To Top

500 W. Baltimore Street, Baltimore, MD 21201-1786 PHONE: (410) 706-7214 FAX: (410) 706-4045 / TDD: (410) 706-7714
Copyright © 2014, University of Maryland Francis King Carey School of Law. All Rights Reserved.

Hotline Hotline



UM | About This Site | Site Map | Contact Us


500 W. Baltimore Street, Baltimore, MD 21201-1786 PHONE: (410) 706-7214 FAX: (410) 706-4045 / TDD: (410) 706-7714

Copyright © 2014, University of Maryland Francis King Carey School of Law. All Rights Reserved